From Medscape Neurology

Coverage from the

International Stroke Conference (ISC) 2018

January 24 - 26, 2018; Los Angeles, California

January 24 - 26, 2018 Los Angeles, California
  • ISC PRISMS: No Benefit of tPA in Mild Stroke Without Disability In the PRISMS trial, thrombolysis provided no benefit in the number of patients achieving good outcomes after a mild stroke without disabling deficits and increased risk for symptomatic intracerebral hemorrhage.
  • ISC Rivaroxaban Plus Aspirin Cuts Stroke Rate in Half New results from the COMPASS trial show combination therapy reduced the ischemic stroke rate by 49% vs aspirin alone in patients with stable vascular disease, without increasing intracerebral bleeding.
  • ISC COMPASS: Aspiration Similar to Stent Retriever in Stroke Results of a new study showing noninferiority of an aspiration device to the stent retriever could change practice patterns in favor of aspiration, researchers say.

Meeting Highlights At A Glance

  • Top News From ISC 2018: Slideshow Top News From ISC 2018: Slideshow Highlights include new stroke guidelines that extend thrombectomy to 24 hours, tenecteplase tops alteplase for stroke thrombolysis, and electrical stimulation eases stroke dysphagia.

Conference News

Popular News from ISC 2017

  • PREMIER: Flow Diversion Effective for Small Aneurysms PREMIER: Flow Diversion Effective for Small Aneurysms Results of a new trial show high occlusion and low retreatment rates of intracranial aneurysms approximately 7 mm in size with the Pipeline Embolization Device, already approved for larger aneurysms.
  • Sitting Up or Lying Flat: Similar Outcomes in Acute Stroke Sitting Up or Lying Flat: Similar Outcomes in Acute Stroke Positioning patients either lying flat or sitting up in the first 24 hours of hospitalization showed no difference in disability or safety outcomes, in a new study.
  • Midlife Vascular Risk Factors Drive Dementia Later in Life Midlife Vascular Risk Factors Drive Dementia Later in Life Vascular risk factors present in midlife raise the risk for dementia later in life, new research confirms. Diabetes is associated with an Alzheimer's risk as high as that seen with carrying the APOE epsilon-4 allele.

Medscape Neurology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

 

Previous Coverage

contact us

www.medicaments-24.net

http://www.medicaments-24.com